194 related articles for article (PubMed ID: 30044793)
21. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
Huang H; Li C; Ren G
Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
[TBL] [Abstract][Full Text] [Related]
23. [B7-H4 expression of salivary gland and sera in patients with primary Sjogren's syndrome].
Yu DL; Li XM; Wang XM; Wang XQ; Li XP
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(39):2775-7. PubMed ID: 23290167
[TBL] [Abstract][Full Text] [Related]
24. Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer.
Wang P; Li C; Zhang F; Ma X; Gai X
Dis Markers; 2018; 2018():4310790. PubMed ID: 30363700
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
Xie N; Cai JB; Zhang L; Zhang PF; Shen YH; Yang X; Lu JC; Gao DM; Kang Q; Liu LX; Zhang C; Huang XY; Zou H; Zhang XY; Song ZJ; Sun HX; Fu BM; Ke AW; Shi GM
Cell Death Dis; 2017 Dec; 8(12):3205. PubMed ID: 29235470
[TBL] [Abstract][Full Text] [Related]
26. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
[No Abstract] [Full Text] [Related]
27. Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.
Mizuno T; Kamai T; Tsuzuki T; Nishihara D; Kijima T; Arai K; Yoshida KI
Cancer Immunol Immunother; 2022 Mar; 71(3):565-578. PubMed ID: 34275008
[TBL] [Abstract][Full Text] [Related]
28. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of B7-H4 is associated with infiltrating immune cells and poor prognosis in metastatic colorectal cancer.
Ding S; Lv X; Liu Z; Zhan S; Xu Y; Zhang X; Liu C; Cao L
Int Immunopharmacol; 2021 Jan; 90():107144. PubMed ID: 33187907
[TBL] [Abstract][Full Text] [Related]
30. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases.
Liang L; Jiang Y; Chen JS; Niu N; Piao J; Ning J; Zu Y; Zhang J; Liu J
Hum Pathol; 2016 Nov; 57():1-6. PubMed ID: 27349304
[TBL] [Abstract][Full Text] [Related]
31. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
Tan Z; Shen W
Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
[TBL] [Abstract][Full Text] [Related]
33. Role of B7-H4 in the Progression and Prognosis of Cervical Inflammation to Cancer After Human Papilloma Virus Infection.
Qiu F; Yuan C; Xu J; Zhang J; Chen F; Liu D; Zheng B; Li R; Huang X; Xu J
J Biomed Nanotechnol; 2019 May; 15(5):1043-1051. PubMed ID: 30890234
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: a Southern China Urology Cancer Consortium Trial.
Xie M; He CS; Huang JK; Lin QZ
Eur J Cancer; 2015 Mar; 51(5):595-603. PubMed ID: 25618828
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a novel double-monoclonal antibody sandwich enzyme-linked immunosorbent assay (ELISA): tool for human B7-H4 detection in autoimmune diseases.
Ding S; Zhou H; Gu Y; Shen Y; Zhang L; Zhao H; Wu J; Zhang X; Chang X; Liu C
Clin Exp Immunol; 2021 Aug; 205(2):150-159. PubMed ID: 33961296
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
37. The immunological role of B7-H4 in pregnant women with Sars-Cov2 infection.
Duan L; Reisch B; Mach P; Kimmig R; Gellhaus A; Iannaccone A
Am J Reprod Immunol; 2022 Dec; 88(6):e13626. PubMed ID: 36121927
[TBL] [Abstract][Full Text] [Related]
38. Prognostic role of high B7-H4 expression in patients with solid tumors: a meta-analysis.
Song X; Shao Y; Gu W; Xu C; Mao H; Pei H; Jiang J
Oncotarget; 2016 Nov; 7(47):76523-76533. PubMed ID: 27058425
[TBL] [Abstract][Full Text] [Related]
39. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.
Simon I; Liu Y; Krall KL; Urban N; Wolfert RL; Kim NW; McIntosh MW
Gynecol Oncol; 2007 Jul; 106(1):112-8. PubMed ID: 17490732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
